Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

New England Journal of Medicine - Tập 380 Số 18 - Trang 1726-1737 - 2019
Noopur Raje1, Jesús G. Berdeja2, Yi Lin3, David S. Siegel4, Sundar Jagannath5, Deepu Madduri5, Michaela Liedtke6, Jacalyn Rosenblatt7, Marcela V. Maus1, Ashley Turka8, Lyh Ping Lam8, Richard A. Morgan8, Kevin M. Friedman8, Monica Massaro8, Julie Wang9, Greg Russotti9, Zhihong Yang9, Timothy B. Campbell10, Kristen Hege10, Fabio Petrocca8, M. Travis Quigley8, Nikhil C. Munshi11, James N. Kochenderfer12
1Massachusetts General Hospital Cancer Center
2Sarah Cannon Research Institute and Tennessee Oncology, Nashville
3Mayo Clinic, Rochester, MN
4Hackensack University Medical Center, Hackensack
5Mount Sinai Medical Center, New York
6Stanford University Medical Center, Palo Alto
7Beth Israel Deaconess Medical Center
8Boston, and Bluebird Bio, Cambridge
9Celgene, Summit
10Celgene, San Francisco
11Dana–Farber Cancer Institute and Veterans Affairs Boston Healthcare System
12Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra1011442

10.1038/nrclinonc.2011.63

10.1038/leu.2013.313

10.1007/s00277-018-3546-8

10.1038/leu.2017.329

10.1007/s11899-011-0083-0

10.1038/leu.2011.196

10.1182/asheducation-2017.1.508

10.1007/s40265-017-0841-y

10.1111/cas.13239

10.1056/NEJMc1800913

10.1182/blood-2017-06-793869

10.1016/S0140-6736(14)61403-3

10.1056/NEJMoa1407222

10.1172/JCI85309

10.1056/NEJMoa1709919

10.1016/j.ymthe.2017.07.004

10.1056/NEJMoa1707447

10.1056/NEJMoa1709866

10.1016/j.ymthe.2016.10.020

10.1200/JCO.2016.34.15_suppl.3011

10.2147/TCRM.S145039

10.2217/imt.15.77

10.1182/blood-2003-06-2043

10.1200/JCO.2018.77.8084

10.1182/blood-2016-04-711903

10.1158/1078-0432.CCR-12-2422

10.1089/hum.2018.001

10.1182/blood-2014-05-552729

Kymriah (tisagenlecleucel). Prescribing information. East Hanover, NJ: Novartis Pharmaceuticals, 2018.

Yescarta (axicabtagene ciloleucel). Prescribing information. Santa Monica, CA: Kite Pharma, 2017.

10.1016/S1470-2045(13)70380-2

10.1016/S0140-6736(15)01120-4

10.1182/blood-2017-08-797886

10.1200/JCO.2017.75.5207

10.1016/S1470-2045(18)30576-X

10.1186/s13045-018-0681-6

10.1182/blood-2017-05-785246

10.1038/s41591-018-0010-1

10.1158/1078-0432.CCR-18-0758

10.1158/1078-0432.CCR-15-1433

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 380 Số 18

1726-1737

Thông tin tác giả